Aerocrine: Interim Report January – June 2012  
7/25/2012 10:34:29 AM

SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News:

Aerocrine: (STO:AEROB)

Continued positive sales development, +88% in the quarter and closing of successful new share issue.

January – June 2012

• Global Net sales grew by 82% to SEK 76.0m (41.8). Adjusted for currency fluctuations, net sales rose by 75% Year over Year (YoY)

• The worldwide number of NIOX MINO® repeat tests sold increased by a total of 50% and for clinical use in the US by 75%